1) Bandelow B, Behnke K, Lenoir S, et al:Sertraline versus paroxetine in the treatment of panic disorder:An acute, double-blind noninferiority comparison. J Clin Psychiatry 65:405-413, 2004
2) Black K, Shea C, Drusum S, et al:Selective serotonin reuptake inhibitor discontinuation syndrome:Proposed diagnostic criteria. J Psychiatry Neurosci 25:255-261, 2005
3) Coupland J, Bell J, Potokar P:Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 16:356-362, 1996
4) Haddad P:The SSRI discontinuation syndrome. J Psychopharmacol 12:305-313, 1998
5) Himei A, Okamura T:Discontinuation syndrome associated with paroxetine in depressed patients:A retrospective analysis of factors involved in the occurrence of the syndrome. CNS Drugs 20:665-672, 2006
6) 加藤忠史,福田倫明,工藤耕太郎,他:Paroxietine離脱症候群を呈した5例.精神医学 45:743-747, 2003
7) 松本好剛,名越泰秀,福居顕二:Paroxetineによる治療中に認められたSSRI(選択的セロトニン再取り込み阻害薬)離脱症候群について(続報).精神科治療学 19:519-522, 2004
8) Okada F:Why dose milnacipran produce so few discontinuation syndromes following abrupt withdrawal? Neuropsychiatr Dis Treat 3:181-182, 2007
9) Price S, Waller C, Wood M, et al:A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol 42:757-763, 1996
10) 竹内賢,星野研洋,鈴木喜明,他:SSRIの中止後発現症状の実態調査.新薬と臨床 24:257-264, 2004
11) Trenque T, Piednoir D, Frances C, et al:Reports of withdrawal syndrome with the use of SSRIs:A case/non-case study in the French Pharmacovigilance database. Pharmacoepidemiol Drug Saf 11:281-283, 2002
12) 上田展久,中村純:Paroxetineによるdiscontinuation syndrome.臨精薬理 11:1821-1826, 2008